Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Dipyridamole 200mg modified-release capsules
0209000L0AAAMAM
|
Dipyridamole | Dipyridamole | Cardiovascular System | 43,997 |
|
Dipyridamole 100mg tablets
0209000L0AAACAC
|
Dipyridamole | Dipyridamole | Cardiovascular System | 3,615 |
|
Dipyridamole 25mg tablets
0209000L0AAABAB
|
Dipyridamole | Dipyridamole | Cardiovascular System | 715 |
|
Dipyridamole 50mg/5ml oral suspension sugar free
0209000L0AAAKAK
|
Dipyridamole | Dipyridamole | Cardiovascular System | 279 |
|
Attia 200mg modified-release capsules
0209000L0BGAAAM
|
Attia | Dipyridamole | Cardiovascular System | 273 |
|
Dipyridamole 200mg/5ml oral suspension sugar free
0209000L0AAAYAY
|
Dipyridamole | Dipyridamole | Cardiovascular System | 22 |
|
Dipyridamole 100mg/5ml oral liquid
0209000L0AAAHAH
|
Dipyridamole | Dipyridamole | Cardiovascular System | 10 |
|
Persantin Retard 200mg capsules (Consilient Health)
0209000L0BBAGAM
|
Persantin | Dipyridamole | Cardiovascular System | 9 |
|
Dipyridamole 10mg/2ml solution for injection ampoules
0209000L0AAAAAA
|
Dipyridamole | Dipyridamole | Cardiovascular System | No data available |
|
Dipyridamole 10mg/5ml oral liquid
0209000L0AAAJAJ
|
Dipyridamole | Dipyridamole | Cardiovascular System | No data available |
|
Dipyridamole 12.5mg/5ml oral liquid
0209000L0AAAUAU
|
Dipyridamole | Dipyridamole | Cardiovascular System | No data available |
|
Dipyridamole 15mg/5ml oral liquid
0209000L0AAARAR
|
Dipyridamole | Dipyridamole | Cardiovascular System | No data available |
|
Dipyridamole 200mg/5ml oral solution
0209000L0AAANAN
|
Dipyridamole | Dipyridamole | Cardiovascular System | No data available |
|
Dipyridamole 200mg/5ml oral suspension
0209000L0AAAZAZ
|
Dipyridamole | Dipyridamole | Cardiovascular System | No data available |
|
Dipyridamole 20mg/5ml oral liquid
0209000L0AAATAT
|
Dipyridamole | Dipyridamole | Cardiovascular System | No data available |
|
Dipyridamole 250mg/5ml oral liquid
0209000L0AAAPAP
|
Dipyridamole | Dipyridamole | Cardiovascular System | No data available |
|
Dipyridamole 25mg/5ml oral liquid
0209000L0AAAQAQ
|
Dipyridamole | Dipyridamole | Cardiovascular System | No data available |
|
Dipyridamole 30mg/5ml oral liquid
0209000L0AAASAS
|
Dipyridamole | Dipyridamole | Cardiovascular System | No data available |
|
Dipyridamole 50mg/5ml oral solution
0209000L0AAALAL
|
Dipyridamole | Dipyridamole | Cardiovascular System | No data available |
|
Dipyridamole 5mg/5ml oral liquid
0209000L0AAAIAI
|
Dipyridamole | Dipyridamole | Cardiovascular System | No data available |
|
Ofcram PR 200mg capsules
0209000L0BHAAAM
|
Ofcram PR | Dipyridamole | Cardiovascular System | No data available |
|
Persantin 100mg tablets
0209000L0BBABAC
|
Persantin | Dipyridamole | Cardiovascular System | No data available |
|
Persantin 10mg/2ml solution for injection ampoules
0209000L0BBACAA
|
Persantin | Dipyridamole | Cardiovascular System | No data available |
|
Persantin 25mg tablets
0209000L0BBAAAB
|
Persantin | Dipyridamole | Cardiovascular System | No data available |
|
Persantin Retard 200mg capsules (Boehringer Ingelheim)
0209000L0BBAFAM
|
Persantin | Dipyridamole | Cardiovascular System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.